BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

  April 22, 2025

   · 

  5 min read
• Press Releases

  BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET

  April 22, 2025

   · 

  1 min read
• Press Releases

  Palvella Therapeutics Granted Additional U.S. Patent for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

  April 22, 2025

   · 

  7 min read
• Press Releases

  OS Therapies FDA Meeting Request Granted

  April 22, 2025

   · 

  5 min read
• 

  Breast cancer

  AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data

  Analysts at Leerink Partners said in a Monday note that DESTINY-Breast09’s findings “could support an approval” for Enhertu in first-line HER2+ metastatic breast cancer.

  April 22, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Breast cancer

  Gilead’s Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer

  Combining Trodelvy with Keytruda and pushing it into the frontline setting could “potentially double” the ADC’s market in metastatic triple-negative breast cancer, according to analysts at Truist Securities.

  April 22, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Cellphire Therapeutics Announces CRYPTICS Phase 2/3 Clinical Study Stopped Early for Efficacy Following Pre-Planned Interim Analysis by Independent Data Monitoring Committee (IDMC)

  April 22, 2025

   · 

  3 min read
• Press Releases

  Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24

  April 22, 2025

   · 

  4 min read
• Press Releases

  Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR

  April 22, 2025

   · 

  7 min read
• Press Releases

  Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day

  April 22, 2025

   · 

  1 min read